These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6363096)

  • 41. Efficacy and tolerability of a new controlled-release formulation of metoprolol: a comparison with conventional metoprolol tablets in mild to moderate hypertension.
    Houtzagers JJ; Smilde JG; Creytens G; Westergren G
    Eur J Clin Pharmacol; 1988; 33 Suppl():S39-44. PubMed ID: 3371393
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ketanserin in the treatment of essential hypertension. A double-blind study against metoprolol and a further long-term open treatment.
    Milei J; Lemus J; Bernardiner E
    Acta Cardiol; 1986; 41(6):427-41. PubMed ID: 3544622
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An evaluation of the effect on resting and exercise blood pressure of some first line treatments in hypertension.
    Lorimer AR; Barbour MB; Lawrie TD
    Ann Clin Res; 1983; 15(1):30-4. PubMed ID: 6859790
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparative study between bisoprolol and metoprolol, combined with hydrochlorothiazide, as antihypertensive therapy].
    Unzueta Montoya A; Unzueta A; Ordóñez Toquero G; Villasis Keever MA; Cocoletzi López J; Medina Santillán R
    Arch Inst Cardiol Mex; 2000; 70(6):589-95. PubMed ID: 11255718
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of a controlled release (CR/ZOK) formulation of metoprolol, once daily, with conventional metoprolol tablets, twice daily, in mild to moderate hypertension.
    Carruthers G; Shearer R; Taylor W; Moore M
    J Clin Pharmacol; 1990 Feb; 30(S2):S61-5. PubMed ID: 2179282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.
    Breithaupt-Grögler K; Gerhardt G; Lehmann G; Notter T; Belz GG
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):425-31. PubMed ID: 9726695
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study.
    Scholze J; Grimm E; Herrmann D; Unger T; Kintscher U
    Circulation; 2007 Apr; 115(15):1991-8. PubMed ID: 17404163
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The pharmacodynamic and pharmacokinetic profiles of controlled-release formulations of felodipine and metoprolol in free and fixed combinations in elderly hypertensive patients.
    McLay JS; MacDonald TM; Hosie J; Elliott HL;
    Eur J Clin Pharmacol; 2000 Nov; 56(8):529-35. PubMed ID: 11151741
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The antihypertensive effects of doxazosin: a clinical overview.
    Cox DA; Leader JP; Milson JA; Singleton W
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):83S-90S. PubMed ID: 2939872
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antihypertensive activity of once daily metoprolol alone and with chlorthalidone and comparison with a twice daily regimen.
    Muiesan G; Agabiti-Rosei E; Carotti A; Corea L; Innocenti P; Montervino C; Prezioso R; Romanelli G; Toso M; Motolese M
    Eur J Clin Pharmacol; 1982; 23(3):209-13. PubMed ID: 6756932
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
    Lyngstam O; Rydén L
    Acta Med Scand; 1981; 209(4):261-6. PubMed ID: 7015797
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Combination antihypertensive therapy in patients with an increased risk profile].
    Bartens W; Nauck M; Wanner C
    Med Klin (Munich); 1996 Oct; 91(10):626-31. PubMed ID: 9019639
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antihypertensive efficacy and tolerability of a fixed combination of metoprolol and felodipine in comparison with the individual substances in monotherapy. The Swedish/United Kingdom Study Group.
    Dahlöf B; Hosie J
    J Cardiovasc Pharmacol; 1990 Dec; 16(6):910-6. PubMed ID: 1704983
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The long-term antihypertensive efficacy and safety of a new felodipine-metoprolol combination tablet. The Swedish/UK and German Study Groups.
    Hosie J; Dahlöf B; Klein G
    Blood Press Suppl; 1993; 1():46-50. PubMed ID: 8173690
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metoprolol in hypertension: an open evaluation.
    Assaykeen TA; Michell G
    Med J Aust; 1982 Jan; 1(2):73-7. PubMed ID: 7040924
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hydrochlorothiazide-amiloride versus hydrochlorothiazide alone for essential hypertension: effects on blood pressure and serum potassium level.
    Larochelle P; Logan AG
    Can Med Assoc J; 1985 Apr; 132(7):801-5. PubMed ID: 3884122
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma levels and pharmacological effects of metoprolol administered as controlled release (Durules) and ordinary tablets in healthy volunteers.
    Johnsson G; Jordö L; Lundborg P; Regårdh CG; Rönn O
    Int J Clin Pharmacol Ther Toxicol; 1980 Jul; 18(7):292-7. PubMed ID: 7000717
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antihypertensive effect of hydrochlorothiazide administered once or twice daily.
    Allen JH; McKenney JM; Stratton MA; Link K
    Clin Pharm; 1982; 1(3):239-43. PubMed ID: 6764388
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Antihypertensive first-line and add-on treatment with a fixed controlled release combination of metoprololsuccinate/hydrochlorothiazide. Prospective doctor's office observational study in 14,964 patients].
    Hildemann SK; Fischer HM; Pittrow D; Bohlscheid V
    Fortschr Med Orig; 2003; 121(1):27-32. PubMed ID: 15117066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.